Friday, August 21, 2026 at 12:00 PM
August 21st, 2026 1.00 AMA PRA Category 1 Credit™ Hours
Description
Hakimeh Ebrahimi-Nik, PhD, The Ohio State University
Dates and Times
Start: 8/21/2026 12:00 PM
End: 8/21/2026 1:00 PM
Objectives
1. Understand the major biological and clinical factors that influence variability in patient responses to cancer immunotherapy.
2. Describe how immune dysfunction contribute to resistance or sensitivity to anti-cancer therapies.
3. Discuss emerging therapeutic strategies aimed at reprogramming the immune system to improve cancer treatment outcomes.
Speakers
Location
DHLRI 170
473 W 12th Ave
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Maggie Murray
Department: Internal Medicine
Phone: (614) 293-3989
Email: Maggie.Murray@osumc.edu